313 related articles for article (PubMed ID: 24529522)
1. The paradox of neuronal insulin action and resistance in the development of aging-associated diseases.
Steculorum SM; Solas M; Brüning JC
Alzheimers Dement; 2014 Feb; 10(1 Suppl):S3-11. PubMed ID: 24529522
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance in the brain: an old-age or new-age problem?
Williamson R; McNeilly A; Sutherland C
Biochem Pharmacol; 2012 Sep; 84(6):737-45. PubMed ID: 22634336
[TBL] [Abstract][Full Text] [Related]
3. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease.
Ferreira ST; Clarke JR; Bomfim TR; De Felice FG
Alzheimers Dement; 2014 Feb; 10(1 Suppl):S76-83. PubMed ID: 24529528
[TBL] [Abstract][Full Text] [Related]
4. Countering neurodegeneration by reducing the activity of the insulin/IGF signaling pathway: current knowledge and future prospects.
Cohen E
Exp Gerontol; 2011; 46(2-3):124-8. PubMed ID: 20849948
[TBL] [Abstract][Full Text] [Related]
5. Selective manipulation of aging: a novel strategy for the treatment of neurodegenerative disorders.
Moll L; El-Ami T; Cohen E
Swiss Med Wkly; 2014 Feb; 144():w13917. PubMed ID: 24526357
[TBL] [Abstract][Full Text] [Related]
6. Insulin and neurodegenerative disease: shared and specific mechanisms.
Craft S; Watson GS
Lancet Neurol; 2004 Mar; 3(3):169-78. PubMed ID: 14980532
[TBL] [Abstract][Full Text] [Related]
7. The role of type 2 diabetes in neurodegeneration.
Verdile G; Fuller SJ; Martins RN
Neurobiol Dis; 2015 Dec; 84():22-38. PubMed ID: 25926349
[TBL] [Abstract][Full Text] [Related]
8. The impairment of insulin signaling in Alzheimer's disease.
Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
[TBL] [Abstract][Full Text] [Related]
9. Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans.
Kullmann S; Heni M; Hallschmid M; Fritsche A; Preissl H; Häring HU
Physiol Rev; 2016 Oct; 96(4):1169-209. PubMed ID: 27489306
[TBL] [Abstract][Full Text] [Related]
10. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
11. Brain insulin signalling in the regulation of energy balance and peripheral metabolism.
Diamant M
Ideggyogy Sz; 2007 Mar; 60(3-4):97-108. PubMed ID: 17451048
[TBL] [Abstract][Full Text] [Related]
12. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.
O' Neill C
Exp Gerontol; 2013 Jul; 48(7):647-53. PubMed ID: 23470275
[TBL] [Abstract][Full Text] [Related]
13. Insulin sensitivity of the human brain.
Ketterer C; Tschritter O; Preissl H; Heni M; Häring HU; Fritsche A
Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S47-51. PubMed ID: 21864751
[TBL] [Abstract][Full Text] [Related]
14. Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases.
Knuesel I
Prog Neurobiol; 2010 Aug; 91(4):257-74. PubMed ID: 20417248
[TBL] [Abstract][Full Text] [Related]
15. Neuronal histaminergic system in aging and age-related neurodegenerative disorders.
Shan L; Swaab DF; Bao AM
Exp Gerontol; 2013 Jul; 48(7):603-7. PubMed ID: 22910064
[TBL] [Abstract][Full Text] [Related]
16. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
Hölscher C
Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Syndrome as a Risk Factor for Alzheimer's Disease: A Focus on Insulin Resistance.
Ezkurdia A; Ramírez MJ; Solas M
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901787
[TBL] [Abstract][Full Text] [Related]
18. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders.
Mattson MP; Maudsley S; Martin B
Trends Neurosci; 2004 Oct; 27(10):589-94. PubMed ID: 15374669
[TBL] [Abstract][Full Text] [Related]
19. Insulin/IGF-like signalling, the central nervous system and aging.
Broughton S; Partridge L
Biochem J; 2009 Feb; 418(1):1-12. PubMed ID: 19159343
[TBL] [Abstract][Full Text] [Related]
20. Dementia, diabetes, Alzheimer's disease, and insulin resistance in the brain: progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics.
Kuljiš RO; Salković-Petrišić M
J Alzheimers Dis; 2011; 25(1):29-41. PubMed ID: 21335659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
